OXURION NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 EUR | 0.00% |
|
0.00% | -88.89% |
| 04-12 | Oxurion NV Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-06 | Oxurion Raises Additional Funds from Convertible Bonds Issue | MT |
Chart calendar Oxurion NV
44dc17706620af9020dc67d68503b1.fS5m4moWcQjFuZFaVu8h9brJ-uVqS57DKHofSkxPwDE.OGUzqjNUAk2wlNJrIrtqnPunvZQMJtGQQQ1mBnV-sEM0R16EA2Q6MLftoQ~496af632e7754d9866aa796b692a96e9
Upcoming events on Oxurion NV
Past events on Oxurion NV
| 15/04/2024 16:16 | Q4 2023 Earnings Release |
| 27/03/2024 | Midcap Conference |
| 28/09/2023 | Q2 2023 Earnings Release |
| 09/06/2023 | Clinical Trials at the Summit |
| 04/06/2023 | BIO International Convention |
| 31/05/2023 | Knowledge for Growth Antwerp Conference |
| 13/05/2023 | BioEquity Europe Conference |
| 02/05/2023 | LSX World Congress |
| 01/05/2023 | Annual General Meeting |
| 31/03/2023 18:00 | Q4 2022 Earnings Release |
| 24/01/2023 | Degroof Petercam Healthcare Conference |
| 08/01/2023 | JPM Biotech Showcase |
| 28/11/2022 | BTIG Ophthalmology Day |
| 13/11/2022 | Investival Showcase |
| 23/10/2022 | BIO Europe Conference |
| 29/09/2022 | American Academy of Ophthalmology Eyecelerator Conference |
| 16/09/2022 16:00 | KBC Securities Life Sciences Conference |
| 12/09/2022 12:00 | H.C. Wainwright Global Investment Conference |
| 07/09/2022 07:25 | Interim 2022 Earnings Release |
| 02/09/2022 11:15 | EURETINA Congress Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 |
|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 3,95 0,00 - | 2,08 0,00 - | 1,13 0,46 147.1% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million EUR | Released Forecast Spread | -52,2 -50,2 -3.99% | -28,6 -36,4 21.33% | -28,5 -32,4 12.11% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -52,1 -49,9 -4.3% | -28,6 -36,4 21.58% | -29,6 -32,4 8.73% |
|
Net income Million EUR | Released Forecast Spread | -51,8 -50,0 -3.76% | -28,0 -36,2 22.7% | -29,2 -31,9 8.54% |
|
EPS EUR | Released Forecast Spread | -1,36 -1,30 -4.62% | -0,75 -0,92 18.48% | -0,77 -0,80 3.75% |
| Announcement Date | 12/03/20 | 17/03/21 | 22/02/22 |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q4 | 2021 S2 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 2,14 0,00 - | 1,26 0,00 - | 0,82 0,00 - | 0,33 0,00 - | 0,40 0,08 384.85% | 0,80 0,08 893.75% |
|
EBIT Million EUR | Released Forecast Spread | -18,8 -17,4 -7.85% | -13,2 -19,6 32.43% | -15,4 -23,1 33.38% | -15,1 -21,5 29.73% | -6,14 -7,98 23.05% | -12,3 -16,6 25.79% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -18,8 -17,3 -8.69% | -13,3 -19,6 31.87% | -15,2 -23,1 33.88% | -16,2 -21,3 23.82% | -6,69 -7,98 16.21% | -13,4 -16,5 19.05% |
|
Net income Million EUR | Released Forecast Spread | -18,5 -17,3 -7.12% | -13,3 -19,6 31.97% | -14,9 -23,1 35.48% | -15,9 -21,3 25.51% | -6,65 -7,81 14.83% | -13,3 -16,5 19.49% |
|
EPS EUR | Released Forecast Spread | -0,49 -0,45 -8.89% | -0,35 -0,41 14.63% | -0,40 -0,52 23.08% | -0,42 -0,43 2.33% | -0,18 -0,17 -5.88% | -0,35 -0,42 16.67% |
| Announcement Date | 12/03/20 | 17/09/20 | 17/03/21 | 09/09/21 | 22/02/22 | 22/02/22 |
More events
Past sector events for Oxurion NV
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OXUR Stock
- Calendar Oxurion NV
